Correlation Between MAIA Biotechnology and Champions Oncology
Can any of the company-specific risk be diversified away by investing in both MAIA Biotechnology and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MAIA Biotechnology and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MAIA Biotechnology and Champions Oncology, you can compare the effects of market volatilities on MAIA Biotechnology and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MAIA Biotechnology with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of MAIA Biotechnology and Champions Oncology.
Diversification Opportunities for MAIA Biotechnology and Champions Oncology
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between MAIA and Champions is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding MAIA Biotechnology and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and MAIA Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MAIA Biotechnology are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of MAIA Biotechnology i.e., MAIA Biotechnology and Champions Oncology go up and down completely randomly.
Pair Corralation between MAIA Biotechnology and Champions Oncology
Given the investment horizon of 90 days MAIA Biotechnology is expected to generate 1.93 times more return on investment than Champions Oncology. However, MAIA Biotechnology is 1.93 times more volatile than Champions Oncology. It trades about 0.08 of its potential returns per unit of risk. Champions Oncology is currently generating about -0.01 per unit of risk. If you would invest 99.00 in MAIA Biotechnology on August 24, 2024 and sell it today you would earn a total of 116.00 from holding MAIA Biotechnology or generate 117.17% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 99.6% |
Values | Daily Returns |
MAIA Biotechnology vs. Champions Oncology
Performance |
Timeline |
MAIA Biotechnology |
Champions Oncology |
MAIA Biotechnology and Champions Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with MAIA Biotechnology and Champions Oncology
The main advantage of trading using opposite MAIA Biotechnology and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MAIA Biotechnology position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Fundamental Analysis View fundamental data based on most recent published financial statements |